ABBOTT LABORATORIES (ABL.DE) Fundamental Analysis & Valuation
FRA:ABL • US0028241000
Current stock price
88.26 EUR
-0.96 (-1.08%)
Last:
This ABL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. ABL.DE Profitability Analysis
1.1 Basic Checks
- ABL had positive earnings in the past year.
- ABL had a positive operating cash flow in the past year.
- ABL had positive earnings in each of the past 5 years.
- In the past 5 years ABL always reported a positive cash flow from operatings.
1.2 Ratios
- ABL has a Return On Assets of 7.52%. This is amongst the best in the industry. ABL outperforms 82.54% of its industry peers.
- ABL has a better Return On Equity (12.51%) than 77.78% of its industry peers.
- The Return On Invested Capital of ABL (9.17%) is better than 74.60% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for ABL is in line with the industry average of 10.21%.
- The last Return On Invested Capital (9.17%) for ABL is above the 3 year average (8.63%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROIC | 9.17% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
1.3 Margins
- The Profit Margin of ABL (14.72%) is better than 84.13% of its industry peers.
- ABL's Profit Margin has improved in the last couple of years.
- ABL's Operating Margin of 18.85% is fine compared to the rest of the industry. ABL outperforms 76.19% of its industry peers.
- ABL's Operating Margin has improved in the last couple of years.
- With a Gross Margin value of 56.68%, ABL perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
- In the last couple of years the Gross Margin of ABL has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% |
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
2. ABL.DE Health Analysis
2.1 Basic Checks
- ABL has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
- Compared to 1 year ago, ABL has more shares outstanding
- Compared to 5 years ago, ABL has less shares outstanding
- ABL has a better debt/assets ratio than last year.
2.2 Solvency
- ABL has an Altman-Z score of 4.86. This indicates that ABL is financially healthy and has little risk of bankruptcy at the moment.
- ABL's Altman-Z score of 4.86 is amongst the best of the industry. ABL outperforms 82.54% of its industry peers.
- ABL has a debt to FCF ratio of 1.75. This is a very positive value and a sign of high solvency as it would only need 1.75 years to pay back of all of its debts.
- ABL has a better Debt to FCF ratio (1.75) than 80.95% of its industry peers.
- ABL has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.
- With a decent Debt to Equity ratio value of 0.19, ABL is doing good in the industry, outperforming 71.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Altman-Z | 4.86 |
ROIC/WACC1.08
WACC8.5%
2.3 Liquidity
- ABL has a Current Ratio of 1.58. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- ABL has a Current ratio (1.58) which is in line with its industry peers.
- ABL has a Quick Ratio of 1.18. This is a normal value and indicates that ABL is financially healthy and should not expect problems in meeting its short term obligations.
- ABL has a Quick ratio of 1.18. This is comparable to the rest of the industry: ABL outperforms 50.79% of its industry peers.
- The current and quick ratio evaluation for ABL is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 |
3. ABL.DE Growth Analysis
3.1 Past
- ABL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.28%, which is quite good.
- ABL shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.13% yearly.
- The Revenue has been growing slightly by 5.67% in the past year.
- ABL shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 5.08% yearly.
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
3.2 Future
- Based on estimates for the next years, ABL will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.38% on average per year.
- The Revenue is expected to grow by 7.06% on average over the next years.
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. ABL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 19.74, the valuation of ABL can be described as rather expensive.
- ABL's Price/Earnings ratio is a bit cheaper when compared to the industry. ABL is cheaper than 73.02% of the companies in the same industry.
- ABL's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.21.
- Based on the Price/Forward Earnings ratio of 17.71, the valuation of ABL can be described as rather expensive.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of ABL is on the same level as its industry peers.
- Compared to an average S&P500 Price/Forward Earnings ratio of 23.10, ABL is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.74 | ||
| Fwd PE | 17.71 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as ABL.
- Based on the Price/Free Cash Flow ratio, ABL is valued a bit cheaper than 63.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 23.9 | ||
| EV/EBITDA | 15.89 |
4.3 Compensation for Growth
- The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- ABL has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)1.71
PEG (5Y)2.77
EPS Next 2Y10.76%
EPS Next 3Y10.34%
5. ABL.DE Dividend Analysis
5.1 Amount
- ABL has a Yearly Dividend Yield of 2.42%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 1.20, ABL pays a bit more dividend than its industry peers.
- ABL's Dividend Yield is a higher than the S&P500 average which is at 1.89.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.42% |
5.2 History
- The dividend of ABL is nicely growing with an annual growth rate of 10.37%!
Dividend Growth(5Y)10.37%
Div Incr Years7
Div Non Decr Years7
5.3 Sustainability
- ABL pays out 63.09% of its income as dividend. This is not a sustainable payout ratio.
- ABL's earnings are growing around the same pace than its dividend. As long as the earnings growth is kept the dividend growth is sustainable.
DP63.09%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
ABL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:ABL (4/7/2026, 5:14:02 PM)
88.26
-0.96 (-1.08%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)01-22 2026-01-22/bmo
Earnings (Next)04-14 2026-04-14/bmo
Inst Owners81.83%
Inst Owner ChangeN/A
Ins Owners0.47%
Ins Owner ChangeN/A
Market Cap153.37B
Revenue(TTM)44.33B
Net Income(TTM)6.52B
Analysts80.57
Price Target114.26 (29.46%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.42% |
Yearly Dividend2.06
Dividend Growth(5Y)10.37%
DP63.09%
Div Incr Years7
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-0.9%
Min EPS beat(2)-1.06%
Max EPS beat(2)-0.75%
EPS beat(4)1
Avg EPS beat(4)-0.41%
Min EPS beat(4)-1.06%
Max EPS beat(4)0.73%
EPS beat(8)3
Avg EPS beat(8)0.09%
EPS beat(12)6
Avg EPS beat(12)0.64%
EPS beat(16)10
Avg EPS beat(16)5.12%
Revenue beat(2)0
Avg Revenue beat(2)-2.58%
Min Revenue beat(2)-3.88%
Max Revenue beat(2)-1.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.72%
Min Revenue beat(4)-3.88%
Max Revenue beat(4)-0.33%
Revenue beat(8)0
Avg Revenue beat(8)-1.18%
Revenue beat(12)3
Avg Revenue beat(12)-0.45%
Revenue beat(16)7
Avg Revenue beat(16)1.23%
PT rev (1m)0%
PT rev (3m)-8.26%
EPS NQ rev (1m)-0.17%
EPS NQ rev (3m)-4.49%
EPS NY rev (1m)0%
EPS NY rev (3m)0.19%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-1.98%
Revenue NY rev (1m)1.08%
Revenue NY rev (3m)0.18%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.74 | ||
| Fwd PE | 17.71 | ||
| P/S | 3.99 | ||
| P/FCF | 23.9 | ||
| P/OCF | 18.48 | ||
| P/B | 3.39 | ||
| P/tB | 7.83 | ||
| EV/EBITDA | 15.89 |
EPS(TTM)4.47
EY5.06%
EPS(NY)4.98
Fwd EY5.65%
FCF(TTM)3.69
FCFY4.18%
OCF(TTM)4.78
OCFY5.41%
SpS22.13
BVpS26.03
TBVpS11.27
PEG (NY)1.71
PEG (5Y)2.77
Graham Number51.17
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.52% | ||
| ROE | 12.51% | ||
| ROCE | 11.9% | ||
| ROIC | 9.17% | ||
| ROICexc | 10.51% | ||
| ROICexgc | 20.3% | ||
| OM | 18.85% | ||
| PM (TTM) | 14.72% | ||
| GM | 56.68% | ||
| FCFM | 16.68% |
ROA(3y)10.6%
ROA(5y)10.1%
ROE(3y)18.49%
ROE(5y)18.82%
ROIC(3y)8.63%
ROIC(5y)9.58%
ROICexc(3y)9.83%
ROICexc(5y)11.21%
ROICexgc(3y)21.64%
ROICexgc(5y)29.96%
ROCE(3y)11.19%
ROCE(5y)12.44%
ROICexgc growth 3Y-22.35%
ROICexgc growth 5Y-6%
ROICexc growth 3Y-8.69%
ROICexc growth 5Y6.09%
OM growth 3Y-1.98%
OM growth 5Y3.67%
PM growth 3Y-2.51%
PM growth 5Y2.53%
GM growth 3Y0.22%
GM growth 5Y-0.03%
F-Score6
Asset Turnover0.51
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | 1.75 | ||
| Debt/EBITDA | 0.86 | ||
| Cap/Depr | 69.67% | ||
| Cap/Sales | 4.9% | ||
| Interest Coverage | 15.33 | ||
| Cash Conversion | 83.39% | ||
| Profit Quality | 113.35% | ||
| Current Ratio | 1.58 | ||
| Quick Ratio | 1.18 | ||
| Altman-Z | 4.86 |
F-Score6
WACC8.5%
ROIC/WACC1.08
Cap/Depr(3y)68.72%
Cap/Depr(5y)62.77%
Cap/Sales(3y)5.22%
Cap/Sales(5y)4.82%
Profit Quality(3y)83.05%
Profit Quality(5y)96.8%
High Growth Momentum
Growth
EPS 1Y (TTM)10.28%
EPS 3Y-1.2%
EPS 5Y7.13%
EPS Q2Q%11.94%
EPS Next Y11.53%
EPS Next 2Y10.76%
EPS Next 3Y10.34%
EPS Next 5Y10.38%
Revenue 1Y (TTM)5.67%
Revenue growth 3Y0.51%
Revenue growth 5Y5.08%
Sales Q2Q%4.42%
Revenue Next Year8.15%
Revenue Next 2Y8%
Revenue Next 3Y7.61%
Revenue Next 5Y7.06%
EBIT growth 1Y18.75%
EBIT growth 3Y-1.48%
EBIT growth 5Y8.93%
EBIT Next Year25.72%
EBIT Next 3Y14.17%
EBIT Next 5Y13.17%
FCF growth 1Y16.44%
FCF growth 3Y-1.78%
FCF growth 5Y5.26%
OCF growth 1Y11.78%
OCF growth 3Y-0.05%
OCF growth 5Y3.9%
ABBOTT LABORATORIES / ABL.DE Fundamental Analysis FAQ
What is the fundamental rating for ABL stock?
ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE.
Can you provide the valuation status for ABBOTT LABORATORIES?
ChartMill assigns a valuation rating of 4 / 10 to ABBOTT LABORATORIES (ABL.DE). This can be considered as Fairly Valued.
How profitable is ABBOTT LABORATORIES (ABL.DE) stock?
ABBOTT LABORATORIES (ABL.DE) has a profitability rating of 8 / 10.
What is the financial health of ABBOTT LABORATORIES (ABL.DE) stock?
The financial health rating of ABBOTT LABORATORIES (ABL.DE) is 8 / 10.
Is the dividend of ABBOTT LABORATORIES sustainable?
The dividend rating of ABBOTT LABORATORIES (ABL.DE) is 5 / 10 and the dividend payout ratio is 63.09%.